Metabolomics Reveals Metabolic Targets and Biphasic Responses in Breast Cancer Cells Treated by Curcumin Alone and in Association with Docetaxel

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Bayet Robert, Mathilde ^a   Morvan, Daniel ^a,b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CENTRE JEAN PERRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; CURCUMIN; DOCETAXEL; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLYCEROPHOSPHOETHANOLAMINE; HOMOCYSTEINE; POLYUNSATURATED FATTY ACID; TAURINE; ANTINEOPLASTIC AGENT; TAXOID;

ARTICLE; CANCER CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DRUG TARGETING; GLUCOSE UTILIZATION; GLUTATHIONE METABOLISM; HORMESIS; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPID STORAGE; METABOLOMICS; PARTIAL LEAST SQUARES REGRESSION; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; UPREGULATION; BREAST TUMOR; COMET ASSAY; FEMALE; INFLAMMATION; MCF 7 CELL LINE; METABOLISM; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; TREATMENT OUTCOME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; COMET ASSAY; CURCUMIN; FEMALE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; INFLAMMATION; MAGNETIC RESONANCE SPECTROSCOPY; MCF-7 CELLS; METABOLOMICS; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; TAXOIDS; TREATMENT OUTCOME;

EID: 84874584067     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057971     Document Type: Article

References (45)

1. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, et al. (2007) Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28: 1765-1773.
2. Shao ZM, Shen ZZ, Liu CH, Sartippour MR, Go VL, et al. (2002) Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 98: 234-240.
3. Karunagaran D, Rashmi R, Kumar TR, (2005) Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets 5: 117-129.
4. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, et al. (1994) Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54: 5841-5847.
5. Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE, (2001) Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47: 293-303.
6. Kuhad A, Pilkhwal S, Sharma S, Tirkey N, Chopra K, (2007) Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. J Agric Food Chem 55: 10150-10155.
7. Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, et al. (2010) Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res 70: 3606-3617.
8. Ganta S, Amiji M, (2009) Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm 6: 928-939.
9. Kamat AM, Sethi G, Aggarwal BB, (2007) Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells. Mol Cancer Ther 6: 1022-1030.
10. Surh YJ, Kundu JK, Na HK, (2008) Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 74: 1526-1539.
11. Kim AN, Jeon WK, Lee JJ, Kim BC, (2010) Up-regulation of heme oxygenase-1 expression through CaMKII-ERK1/2-Nrf2 signaling mediates the anti-inflammatory effect of bisdemethoxycurcumin in LPS-stimulated macrophages. Free Radic Biol Med 49: 323-331.
12. Garg R, Gupta S, Maru GB, (2008) Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: mechanism of its anti-initiating action. Carcinogenesis 29: 1022-1032.
13. Fang J, Lu J, Holmgren A, (2005) Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem 280: 25284-25290.
14. Hong J, Bose M, Ju J, Ryu JH, Chen X, et al. (2004) Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25: 1671-1679.
15. Cao J, Jia L, Zhou HM, Liu Y, Zhong LF, (2006) Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicol Sci 91: 476-483.
16. Sandur SK, Ichikawa H, Pandey MK, Kunnumakkara AB, Sung B, et al. (2007) Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 43: 568-580.
17. Barzegar A, Moosavi-Movahedi AA, (2011) Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PLoS One 10: e26012.
18. Chan WH, Wu HJ, Hsuuw YD, (2005) Curcumin inhibits ROS formation and apoptosis in methylglyoxal-treated human hepatoma G2 cells. Ann N Y Acad Sci 1042: 372-378.
19. Tiziani S, Lodi A, Khanim FL, Viant MR, Bunce CM, et al. (2009) Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines. PLoS One 4: e4251.
20. Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, et al. (2002) Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res 62: 3868-3875.
21. Banerjee M, Singh P, Panda D, (2010) Curcumin suppresses the dynamic instability of microtubules, activates the mitotic checkpoint and induces apoptosis in MCF-7 cells. FEBS J 277: 3437-3448.
22. Morvan D, Demidem A, (2007) Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways. Cancer Res 67: 2150-2159.
23. Tan G, Lou Z, Liao W, Zhu Z, Dong X, et al. (2011) Potential biomarkers in mouse myocardium of doxorubicin-induced cardiomyopathy: a metabonomic method and its application. PLoS One 6: e27683.
24. Massimi M, Tomassini A, Sciubba F, Sobolev AP, Devirgiliis LC, et al. (2012) Effects of resveratrol on HepG2 cells as revealed by (1)H-NMR based metabolic profiling. Biochim Biophys Acta 1820: 1-8.
25. Bayet-Robert M, Kwiatkowski F, Leheurteur M, Gachon F, Planchat E, et al. (2010) Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther 9: 8-14.
26. Hininger I, Chollat-Namy A, Sauvaigo S, Osman M, Faure H, et al. (2004) Assessment of DNA damage by comet assay on frozen total blood: method and evaluation in smokers and non-smokers. Mutat Res 558: 75-80.
27. Bayet-Robert M, Lim S, Barthomeuf C, Morvan D, (2010) Biochemical disorders induced by cytotoxic marine natural products in breast cancer cells as revealed by proton NMR spectroscopy-based metabolomics. Biochem Pharmacol 80: 1170-1179.
28. Bayet-Robert M, Loiseau D, Rio P, Demidem A, Barthomeuf C, et al. (2010) Quantitative two-dimensional HRMAS 1H-NMR spectroscopy-based metabolite profiling of human cancer cell lines and response to chemotherapy. Magn Reson Med 63: 1172-1183.
29. Syng-Ai C, Kumari AL, Khar A, (2004) Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther 3: 1101-1108.
30. Lavoie S, Chen Y, Dalton TP, Gysin R, Cuenod M, et al. (2009) Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit. J Neurochem 108: 1410-1422.
31. Biswas SK, McClure D, Jimenez LA, Megson IL, Rahman I, (2005) Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal 7: 32-41.
32. Zhou H, Beevers CS, Huang S, (2011) The targets of curcumin. Curr Drug Targets 12: 332-347.
33. Hayeshi R, Mutingwende I, Mavengere W, Masiyanise V, Mukanganyama S, (2007) The inhibition of human glutathione S-transferases activity by plant polyphenolic compounds ellagic acid and curcumin. Food Chem Toxicol 45: 286-295.
34. Erlank H, Elmann A, Kohen R, Kanner J, (2011) Polyphenols activate Nrf2 in astrocytes via H2O2, semiquinones, and quinones. Free Radic Biol Med 51: 2319-2327.
35. Balogun E, Hoque M, Gong P, Killeen E, Green CJ, et al. (2003) Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371: 887-895.
36. Santel T, Pflug G, Hemdan NY, Schafer A, Hollenbach M, et al. (2008) Curcumin inhibits glyoxalase 1: a possible link to its anti-inflammatory and anti-tumor activity. PLoS One 3: e3508.
37. Hakumaki JM, Poptani H, Sandmair AM, Yla-Herttuala S, Kauppinen RA, (1999) 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. Nat Med 5: 1323-1327.
38. Delikatny EJ, Chawla S, Leung DJ, Poptani H, (2011) MR-visible lipids and the tumor microenvironment. NMR Biomed 24: 592-611.
39. Camacho-Barquero L, Villegas I, Sanchez-Calvo JM, Talero E, Sanchez-Fidalgo S, et al. (2007) Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol 7: 333-342.
40. Lee YK, Park SY, Kim YM, Park OJ, (2009) Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Ann N Y Acad Sci 1171: 489-494.
41. Weiner J, 3rd, Parida SK, Maertzdorf J, Black GF, Repsilber D, et al (2012) Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients. PLoS One 7: e40221.
42. Beinke S, Ley SC, (2004) Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J 382: 393-409.
43. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, et al. (1998) Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64: 353-356.
44. Birringer M, (2011) Hormetics: dietary triggers of an adaptive stress response. Pharm Res 28: 2680-2694.
45. Hurd TR, Collins Y, Abakumova I, Chouchani ET, Baranowski B, et al. (2012) Inactivation of pyruvate dehydrogenase kinase 2 by mitochondrial reactive oxygen species. J Biol Chem 287: 35153-35160.